Infinity Pharmaceuticals, Inc.

NasdaqGS:INFI Stock Report

Mkt Cap: US$58.1m

Infinity Pharmaceuticals Future Growth

How is Infinity Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


9.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:INFI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025N/A-53N/AN/A1
12/31/2024N/A-46N/AN/A1
12/31/20232-42N/AN/A2
9/30/20223-47-43-43N/A
6/30/20222-47-42-42N/A
3/31/20222-46-41-41N/A
12/31/20212-45-41-41N/A
9/30/20212-44-39-39N/A
6/30/20212-43-39-39N/A
3/31/20212-41-37-37N/A
12/31/20202-40-36-36N/A
9/30/20202-41-37-36N/A
6/30/20201-43-40-38N/A
3/31/20201-44-40-38N/A
12/31/20193-47-44-42N/A
9/30/20193-44-18-16N/A
6/30/201925-19-14-13N/A
3/31/201924-16-11-11N/A
12/31/201822-11-5-5N/A
9/30/201822-10-20-20N/A
6/30/20186-31-24-24N/A
3/31/20186-41-29-29N/A
12/31/20176-42-37-37N/A
9/30/20176-57-59-59N/A
6/30/2017N/A-70-83-83N/A
3/31/201790-120-120N/A
12/31/201619-30-155-154N/A
9/30/201628-46-52-51N/A
6/30/201611915N/A-50N/A
3/31/2016114-76N/A-36N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: INFI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: INFI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: INFI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: INFI's revenue (44.1% per year) is forecast to grow faster than the US market (6.9% per year).

High Growth Revenue: INFI's revenue (44.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if INFI's Return on Equity is forecast to be high in 3 years time


Discover growth companies